Cargando…
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression
Since the start of the SARS-CoV-2 pandemic, several treatments have been proposed to prevent the progression of the disease. Currently, three antiviral (molnupiravir, nirmaltrevir/r, remdesivir) and two monoclonal antibodies (casirivimab/imdevimab and sotrovimab) are available in Italy. Therefore, w...
Autores principales: | De Vito, Andrea, Colpani, Agnese, Saderi, Laura, Puci, Mariangela, Zauli, Beatrice, Fiore, Vito, Fois, Marco, Meloni, Maria Chiara, Bitti, Alessandra, Di Castri, Cosimo, Maida, Ivana, Babudieri, Sergio, Sotgiu, Giovanni, Madeddu, Giordano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865563/ https://www.ncbi.nlm.nih.gov/pubmed/36680111 http://dx.doi.org/10.3390/v15010071 |
Ejemplares similares
-
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?
por: De Vito, Andrea, et al.
Publicado: (2023) -
Safety and efficacy of molnupiravir in SARS‐CoV‐2‐infected patients: A real‐life experience
por: De Vito, Andrea, et al.
Publicado: (2022) -
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study
por: De Vito, Andrea, et al.
Publicado: (2023) -
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience
por: Donisi, Alessandra, et al.
Publicado: (2023) -
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population
por: De Vito, Andrea, et al.
Publicado: (2022)